CBMG Stock Ownership Activity

CELLULAR BIOMEDICINE GROUP I 13F holders

No value investing guru has made any change to the CELLULAR BIOMEDICINE GROUP I (CBMG) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying CBMG now?

According to the latest SEC filing(s) CELLULAR BIOMEDICINE GROUP I (CBMG) has not been purchased by any super investor.

To see more about who is investing in CELLULAR BIOMEDICINE GROUP I (CBMG), please go to the CBMG ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2021 Q1 (1 result)
Prem Watsa
Fairfax Financial Holdings
-100.00%
-8,600
-0.01%
0.00%
Reported price*: $18.37
2020 Q4 (1 result)
Prem Watsa
Fairfax Financial Holdings
buy
+8,600
+0.01%
0.00%
Reported price*: $18.37
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.